Privately held Creatv MicroTech, led by MIT-trained scientist and founder Cha-Mei Tang, is known for bringing diagnostics together with microfabrication to develop cancer research technologies. Its Creatv Bio division applies that expertise to blood-based liquid-biopsy research for cancer screening and treatment monitoring, including work with biopharma companies and clinical-trial sponsors. Creatv MicroTech received an R&D 100 Award in 2006 and was named Montgomery County’s Biotech Company of the Year in 2013.
ANPAC Bio-Medical Science Co., LtdFounded in 2010 by scientists spanning medicine, physics, biology, biochemistry and nanotechnology, ANPAC Bio-Medical Science develops multi-cancer detection and early cancer-risk screening technologies. The company’s patented Cancer Differentiation Analysis approach has been used in more than 300,000 multi-cancer test samples, supporting screening for cancer risks in the general population.AMBLER, PA
ACUITYnano LLCMaryland-based ACUITYnano LLC develops biomedical and laboratory technologies that use microfluidics, optics, machine vision, and embedded control to manipulate and study nanoscale objects and living cells. Its R&D work ranges from a low-cost on-chip near-field optical microscope with reported 10-nanometer resolution to automated systems for cell and nematode analysis, including research designed for microgravity experiments. The company also helps research organizations, startups, and medical-device businesses move concepts from early development into prototypes and products.CHEVY CHASE, MD
20/20 BioLabsFounded by Jonathan Cohen, 20/20 BioLabs develops and commercializes AI-powered laboratory blood tests aimed at detecting cancer and chronic disease earlier. Its OneTest for Cancer uses a protein tumor-marker approach and can be collected at home with an upper-arm device, while the company’s longevity test measures inflammation-related biomarkers to support proactive health decisions. The company’s laboratory is CAP accredited and CLIA licensed, and its multi-cancer test has performed in blinded studies conducted by the U.S. National Cancer Institute.GAITHERSBURG, MD
Ultrasonic Medical Mapping, IncBethesda-based Ultrasonic Medical Mapping develops radiation-free cancer-detection technology, adapting a mature method from defense and aerospace testing for medical use. Its patented system is focused on finding pancreatic tumors earlier and at smaller sizes than existing imaging and non-imaging technologies, and the company has built a preclinical prototype for technical validation. UMM is now working toward clinical testing with hospital and clinical partners.BETHESDA, MD